Search details
1.
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line.
J Transl Med
; 22(1): 329, 2024 Apr 03.
Article
in English
| MEDLINE | ID: mdl-38570798
2.
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.
Cancer Immunol Immunother
; 72(7): 2217-2231, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36869232
3.
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.
J Transl Med
; 21(1): 626, 2023 09 15.
Article
in English
| MEDLINE | ID: mdl-37715207
4.
Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients.
Int J Mol Sci
; 24(8)2023 Apr 12.
Article
in English
| MEDLINE | ID: mdl-37108276
5.
Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis.
Int J Mol Sci
; 23(22)2022 Nov 21.
Article
in English
| MEDLINE | ID: mdl-36430974
6.
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.
Int J Mol Sci
; 23(11)2022 Jun 05.
Article
in English
| MEDLINE | ID: mdl-35682991
7.
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
Gynecol Oncol
; 150(1): 151-157, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29753392
8.
Profiles of cancer stem cell subpopulations in cholangiocarcinomas.
Am J Pathol
; 185(6): 1724-39, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25892683
9.
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells.
Int J Cancer
; 134(8): 1823-34, 2014 Apr 15.
Article
in English
| MEDLINE | ID: mdl-24150888
10.
The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells.
J Hepatol
; 61(5): 1097-105, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-24953023
11.
Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder.
J Hepatol
; 60(6): 1194-202, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24530598
12.
Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis.
BMC Gastroenterol
; 14: 204, 2014 Dec 04.
Article
in English
| MEDLINE | ID: mdl-25471120
13.
Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation.
Eur J Immunol
; 42(4): 936-45, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-22531918
14.
A standardized laboratory and surgical method for in vitro culture isolation and expansion of primary human Tenon's fibroblasts.
Cell Tissue Bank
; 14(2): 277-87, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-22820760
15.
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity.
J Immunol Res
; 2023: 2344239, 2023.
Article
in English
| MEDLINE | ID: mdl-37114204
16.
Proteomic characterization of extracellular vesicles released by third stage larvae of the zoonotic parasite Anisakis pegreffii (Nematoda: Anisakidae).
Front Cell Infect Microbiol
; 13: 1079991, 2023.
Article
in English
| MEDLINE | ID: mdl-37009516
17.
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors.
Front Immunol
; 14: 1199089, 2023.
Article
in English
| MEDLINE | ID: mdl-37483633
18.
Thinking twice before abandoning first-line chemotherapy in ovarian cancer: report of two cases and literature review. Passing from tri-weekly to weekly regimens.
Int J Clin Oncol
; 17(4): 385-9, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-21892670
19.
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: Relief from immunosuppression is associated with clinical response.
EBioMedicine
; 79: 104010, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35477069
20.
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer.
Clin Cancer Res
; 28(5): 1027-1037, 2022 Mar 01.
Article
in English
| MEDLINE | ID: mdl-34980602